npj Precision Oncology (Nov 2022)
Author Correction: Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
- Sumeet Hindocha,
- Thomas G. Charlton,
- Kristofer Linton-Reid,
- Benjamin Hunter,
- Charleen Chan,
- Merina Ahmed,
- Emily J. Greenlay,
- Matthew Orton,
- Catey Bunce,
- Jason Lunn,
- Simon J. Doran,
- Shahreen Ahmad,
- Fiona McDonald,
- Imogen Locke,
- Danielle Power,
- Matthew Blackledge,
- Richard W. Lee,
- Eric O. Aboagye
Affiliations
- Sumeet Hindocha
- Lung Unit, The Royal Marsden NHS Foundation Trust
- Thomas G. Charlton
- Guy’s Cancer Centre, Guy’s and St Thomas’ NHS Foundation Trust
- Kristofer Linton-Reid
- Cancer Imaging Centre, Department of Surgery & Cancer, Imperial College London
- Benjamin Hunter
- Lung Unit, The Royal Marsden NHS Foundation Trust
- Charleen Chan
- Institute of Cancer Research NIHR Biomedical Research Centre
- Merina Ahmed
- Lung Unit, The Royal Marsden NHS Foundation Trust
- Emily J. Greenlay
- Clinical Trials Unit, Royal Marsden NHS Foundation Trust
- Matthew Orton
- Artificial Intelligence Imaging Hub, Royal Marsden NHS Foundation Trust
- Catey Bunce
- Clinical Trials Unit, Royal Marsden NHS Foundation Trust
- Jason Lunn
- Institute of Cancer Research NIHR Biomedical Research Centre
- Simon J. Doran
- Institute of Cancer Research NIHR Biomedical Research Centre
- Shahreen Ahmad
- Guy’s Cancer Centre, Guy’s and St Thomas’ NHS Foundation Trust
- Fiona McDonald
- Lung Unit, The Royal Marsden NHS Foundation Trust
- Imogen Locke
- Lung Unit, The Royal Marsden NHS Foundation Trust
- Danielle Power
- Department of Clinical Oncology, Charing Cross Hospital
- Matthew Blackledge
- Radiotherapy and Imaging, Institute of Cancer Research
- Richard W. Lee
- Lung Unit, The Royal Marsden NHS Foundation Trust
- Eric O. Aboagye
- Cancer Imaging Centre, Department of Surgery & Cancer, Imperial College London
- DOI
- https://doi.org/10.1038/s41698-022-00332-1
- Journal volume & issue
-
Vol. 6,
no. 1
pp. 1 – 1
Abstract
No abstracts available.